Circulating FGF21 Concentration, Fasting Plasma Glucose, and the Risk of Type 2 Diabetes: Results From the PREVEND Study

OBJECTIVE: Fibroblast growth factor 21 (FGF21) is a peptide hormone synthesized by several organs and regulates, among others, energy homeostasis. In obesity, insulin resistance and type 2 diabetes (T2D), higher circulating FGF21 concentrations have been found. Temporal analyses in murine studies de...

Descripción completa

Detalles Bibliográficos
Autores principales: Post, Adrian, Dam, Wendy A, Sokooti, Sara, Groothof, Dion, Gloerich, Jolein, van Gool, Alain J, Kremer, Daan, Gansevoort, Ron T, van den Born, Jacob, Kema, Ido P, Franssen, Casper F M, Dullaart, Robin P F, Bakker, Stephan J L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Clinical Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188302/
https://www.ncbi.nlm.nih.gov/pubmed/36533509
http://dx.doi.org/10.1210/clinem/dgac729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188302/
https://www.ncbi.nlm.nih.gov/pubmed/36533509
http://dx.doi.org/10.1210/clinem/dgac729

Ejemplares similares